Key result
NSRT in HOCM is linked to increased LV passive filling and reduced LA size.
Why the study?
While nonsurgical septal reduction therapy reduces LVOT obstruction and improves symptoms in HOCM, its effect on LV passive filling volume, LA volumes, and LA function was unknown.
Does nonsurgical septal reduction therapy improve left ventricular filling and left atrial function in patients with hypertrophic obstructive cardiomyopathy?
Population
30 patients with hypertrophic obstructive cardiomyopathy (HOCM) and 12 age-matched normal subjects
Comparison
Nonsurgical septal reduction therapy (NSRT) vs Baseline and age-matched normal subjects
Design
Cohort
Follow-up
6 months
Authors
Loading...
Nonsurgical septal reduction therapy for HOCM improves LV passive filling and reduces LA size and mechanical burden at 6 months.
Observational (n=42)
Does nonsurgical septal reduction therapy improve left ventricular filling and left atrial function in patients with hypertrophic obstructive cardiomyopathy?
p-value: p=<0.01
Nonsurgical septal reduction therapy for HOCM improves LV passive filling and reduces LA size and mechanical burden at 6 months.
Nagueh et al. (1999) conducted an observational in Hypertrophic obstructive cardiomyopathy (HOCM) (n=42). Nonsurgical septal reduction therapy (NSRT) vs. Baseline and age-matched normal subjects was evaluated on Changes in left ventricular passive filling volume, left atrial volumes, ejection force, and kinetic energy (p=<0.01). Nonsurgical septal reduction therapy in HOCM patients significantly increased LV passive filling volume and reduced LA size, ejection force, and kinetic energy at 6 months (p<0.01).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: